Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hepatology
Volume 2012 (2012), Article ID 138381, 3 pages
http://dx.doi.org/10.1155/2012/138381
Case Report

Reversal of Jaundice in Two Patients with Inoperable Cholangiocarcinoma Treated with Cisplatin and Gemcitabine Combination

1Department of Medical Oncology, Regionaal Ziekenhuis SINT MARIA, Ziekenhuislaan 100, 1500 Halle, Belgium
2Department of Gastroenterology, Regionaal Ziekenhuis SINT MARIA, Ziekenhuislaan 100, 1500 Halle, Belgium

Received 30 November 2011; Accepted 17 January 2012

Academic Editors: F. Pérez Roldán and H. Uchiyama

Copyright © 2012 Maarten Criel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Blechacz, M. Komuta, T. Roskams, and G. J. Gores, “Clinical diagnosis and staging of cholangiocarcinoma,” Nature Reviews Gastroenterology and Hepatology, vol. 8, no. 9, pp. 512–522, 2011. View at Publisher · View at Google Scholar · View at PubMed
  2. C. D. Anderson, C. W. Pinson, J. Berlin, and R. S. Chari, “Diagnosis and treatment of cholangiocarcinoma,” Oncologist, vol. 9, no. 1, pp. 43–57, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Tajiri, H. Yoshida, Y. Mamada, N. Taniai, S. Yokomuro, and Y. Mizuguchi, “Diagnosis and initial management of cholangiocarcinoma with obstructive jaundice,” World Journal of Gastroenterology, vol. 14, no. 19, pp. 3000–3005, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. I. De Vreede, J. L. Steers, P. A. Burch et al., “Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma,” Liver Transplantation, vol. 6, no. 3, pp. 309–316, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. H. Witzigmann, F. Berr, U. Ringel et al., “Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to R1/R2 resection,” Annals of Surgery, vol. 244, no. 2, pp. 230–239, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. Y. K. Cheon, “The role of photodynamic therapy for hilar cholangiocarcinoma,” Korean Journal of Internal Medicine, vol. 25, no. 4, pp. 345–352, 2010. View at Publisher · View at Google Scholar · View at PubMed
  7. J. A. Richter and M. Kahaleh, “Photodynamic therapy: Palliation and endoscopic technique in cholangiocarcinoma,” World Journal of Gastrointestinal Endoscopy, vol. 2, no. 11, pp. 357–361, 2010. View at Google Scholar
  8. T. B. Brunner and C. L. Eccles, “Radiotherapy and chemotherapy as therapeutic strategies in extrahepatic biliary duct carcinoma,” Strahlentherapie und Onkologie, vol. 186, no. 12, pp. 672–680, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. F. Eckel, T. Brunner, and S. Jelic, “Biliary cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up,” Annals of Oncology, vol. 22, supplement 6, pp. vi40–vi44, 2011. View at Publisher · View at Google Scholar · View at PubMed
  10. M. J. Kim, D. Y. Oh, S. H. Lee et al., “Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study,” BMC Cancer, vol. 8, article no. 374, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. J. Valle, H. Wasan, D. H. Palmer et al., “Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer,” New England Journal of Medicine, vol. 362, no. 14, pp. 1273–1281, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. O. Nehls, H. Oettle, J. T. Hartmann et al., “Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial,” British Journal of Cancer, vol. 98, no. 2, pp. 309–315, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. A. K. Charalabopoulos, S. P. Krivan, N. A. MacHairas, E. P. Misiakos, and A. N. MacHairas, “Endopancreatic bile duct cholangiocarcinoma in a patient with peutz-jeghers syndrome,” HPB Surgery, vol. 2011, Article ID 364570, 4 pages, 2011. View at Publisher · View at Google Scholar · View at PubMed
  14. N. Razumilava and G. J. Gores, “Combination of gemcitabine and cisplatin for biliary tract cancer: a platform to build on,” Journal of Hepatology, vol. 54, no. 3, pp. 577–578, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. M Gabrovska, F Geurs, S Ponette et al., “Weekly cisplatin may reverse liver dysfunction and jaundice caused by diffuse liver metastases of solid tumors,” Hepatic Medicine: Evidence and Research, vol. 1, pp. 9–12, 2009. View at Google Scholar